These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7825022)

  • 1. Partial purification and characterization of DNA topoisomerase II from Plasmodium falciparum.
    Chavalitshewinkoon P; Leelaphiwat S; Wilairat P
    Southeast Asian J Trop Med Public Health; 1994 Mar; 25(1):32-6. PubMed ID: 7825022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial purification of mitochondrial DNA topoisomerase II from Plasmodium falciparum and its sensitivity to inhibitors.
    Chavalitshewinkoon-Petmitr P; Worasing R; Wilairat P
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):733-8. PubMed ID: 12041546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial purification and characterization of Trichomonas vaginalis DNA topoisomerase II.
    Sithiprom S; Petmitr S; Chavalitshewinkoon-Petmitr P
    Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):877-85. PubMed ID: 19842367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cleavage of DNA induced by 9-anilinoacridine inhibitors of topoisomerase II in the malaria parasite Plasmodium falciparum.
    Auparakkitanon S; Wilairat P
    Biochem Biophys Res Commun; 2000 Mar; 269(2):406-9. PubMed ID: 10708566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of Trichomonas vaginalis to DNA topoisomerase II inhibitors.
    Petmitr PC; Ramdja M; Kajorndechakiat S
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):118-22. PubMed ID: 11023077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium falciparum: stage-related expression of topoisomerase I.
    Tosh K; Cheesman S; Horrocks P; Kilbey B
    Exp Parasitol; 1999 Feb; 91(2):126-32. PubMed ID: 9990340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous purification of DNA topoisomerase I and II from eukaryotic cells.
    Strausfeld U; Richter A
    Prep Biochem; 1989; 19(1):37-48. PubMed ID: 2544867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties.
    Har-Vardi I; Mali R; Breietman M; Sonin Y; Albotiano S; Levitas E; Potashnik G; Priel E
    Hum Reprod; 2007 Aug; 22(8):2183-9. PubMed ID: 17656417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased sensitivity to quinolone antibacterials can be engineered in human topoisomerase IIalpha by selective mutagenesis.
    Hammonds TR; Foster SR; Maxwell A
    J Mol Biol; 2000 Jul; 300(3):481-91. PubMed ID: 10884345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum.
    Weissig V; Vetro-Widenhouse TS; Rowe TC
    DNA Cell Biol; 1997 Dec; 16(12):1483-92. PubMed ID: 9428797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
    Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
    Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo topoisomerase II cleavage sites in the ribosomal DNA of Physarum polycephalum.
    Borde V; Duguet M
    Biochemistry; 1996 May; 35(18):5787-95. PubMed ID: 8639539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A temperature sensitive topoisomerase II allele confers temperature dependent drug resistance on amsacrine and etoposide: a genetic system for determining the targets of topoisomerase II inhibitors.
    Nitiss JL; Liu YX; Hsiung Y
    Cancer Res; 1993 Jan; 53(1):89-93. PubMed ID: 8380128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An atypical type II topoisomerase from Mycobacterium smegmatis with positive supercoiling activity.
    Jain P; Nagaraja V
    Mol Microbiol; 2005 Dec; 58(5):1392-405. PubMed ID: 16313624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast topoisomerase II mutants resistant to anti-topoisomerase agents: identification and characterization of new yeast topoisomerase II mutants selected for resistance to etoposide.
    Liu YX; Hsiung Y; Jannatipour M; Yeh Y; Nitiss JL
    Cancer Res; 1994 Jun; 54(11):2943-51. PubMed ID: 8187080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topoisomerases of kinetoplastid parasites: why so fascinating?
    Das BB; Sengupta T; Ganguly A; Majumder HK
    Mol Microbiol; 2006 Nov; 62(4):917-27. PubMed ID: 17042788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active DNA topoisomerase II with minimum molecular mass from regenerating rat liver.
    Park SH; Lee CG; Namkung R; Kim CG; Park SD
    Biochem Mol Biol Int; 1994 Mar; 32(4):641-50. PubMed ID: 8038715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and biological evaluation of a series of fluoroquinoanthroxazines with contrasting dual mechanisms of action against topoisomerase II and G-quadruplexes.
    Kim MY; Duan W; Gleason-Guzman M; Hurley LH
    J Med Chem; 2003 Feb; 46(4):571-83. PubMed ID: 12570378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolones as enhancers of camptothecin-induced cytotoxic and anti-topoisomerase I effects.
    Reuveni D; Halperin D; Shalit I; Priel E; Fabian I
    Biochem Pharmacol; 2008 Mar; 75(6):1272-81. PubMed ID: 18191106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.